Armed Forces Institute of Pathology to Conduct NanoViricides Animal Studies against Bird Flu

WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), announced today that they have executed a Cooperative Research and Development Agreement (CRADA) with the Armed Forces Institute of Pathology (AFIP). This joint R&D effort will enable AFIP scientists to test the effectiveness of several NanoViricides, Inc. anti-viral nanomedicines against deadly bird flu viruses (H5N1) at their facilities.